Safety and effectiveness of once-yearly zoledronic acid in Japanese osteoporosis patients: three-year post-marketing surveillance

INTRODUCTION: Zoledronic acid (5 mg; ZOL), a once-yearly bisphosphonate, reduces osteoporotic fractures and increases bone mineral density (BMD). This 3-year post-marketing surveillance examined its real-world safety and effectiveness. MATERIALS AND METHODS: This prospective, observational study inc...

Descripción completa

Detalles Bibliográficos
Autores principales: Takada, Junichi, Sato, Shizu, Arai, Kouichi, Kito, Yoriko, Oshita, Yuko, Saito, Kazuko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Nature Singapore 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9978276/
https://www.ncbi.nlm.nih.gov/pubmed/36862212
http://dx.doi.org/10.1007/s00774-023-01410-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9978276/
https://www.ncbi.nlm.nih.gov/pubmed/36862212
http://dx.doi.org/10.1007/s00774-023-01410-5

Ejemplares similares